Catalysts for $ADCT
6 tracked
May 4, 2026
earnings
ADC Therapeutics SA earnings
ADC Therapeutics SA
→
Feb 20, 2026
approval
ZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approval
loncastuximab tesirine
→
Jan 16, 2026
approval
ZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approval
loncastuximab tesirine
→
Oct 12, 2022
approval
ZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approval
loncastuximab tesirine
→
Oct 12, 2022
approval
ZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approval
loncastuximab tesirine
→
Apr 23, 2021
approval
ZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approval
loncastuximab tesirine
→